Fibrinogen Otsu I:A γ Asn319,Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant woman

• References

• 1 http://www.geht.org/pages/database_fibrino_uk.html
• 2 Koopman J, Haverkate F, Briet E. et al. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the γ-chain gene, causing defective calcium binding and impaired fibrin polymerization. J Biol Chem 1991; 266: 13456-61.
• 3 Haverkate S, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrino-gen. Thromb Haemost 1995; 73: 151-61.
• 4 Terasawa F, Okumura N, Kitano K. et al. Hypofibrinogenemia associates with a heterozygous missense mutation γ153Cys to Arg (Matsumoto IV): In vitro expression demonstrates defective secretion of the variant fibrinogen. Blood 1999; 94: 4122-31.
• 5 Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recombinant fibrinogen γ-364 Asp His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272: 29596-601.
• 6 Hogan KA, Gorkun OV, Lounes KC. et al. Recombinant fibrinogen Vlissingen/Frank-furt IV. J Biol Chem 2000; 275: 17778-85.
• 7 Hogan KA, Lord ST, Okumura N. et al. A functional assay suggests that heterodimers exist in two C-terminal γ-chain dysfibrino-gens: Matsumoto I and Vlissingen/Frankfurt IV. Thromb Haemost 2000; 83: 592-5.